Nasdaq
HUMA
Humacyte, Inc.
- Health Care
- Listed 2020
- 1 day
- −2.6%
- 1 month
- −8.0%
- 1 year
- −67.9%
$0.7096 · Mkt cap $158M
At the 6 Aug 2026 close
Nasdaq
Humacyte, Inc.
$0.7096 · Mkt cap $158M
At the 6 Aug 2026 close
Humacyte, Inc. trades under the ticker HUMA on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $158M. The last closing price was $0.7096, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −67.9%, and −8.0% over the past month. Returns are price returns and exclude dividends.
This page exists because HUMA is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.